• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

APOLLO ENDOSURGERY, INC. ORBERA INTRAGASTRIC BALLOON SYSTEM Back to Search Results
Model Number B-50000
Device Problems Use of Device Problem (1670); Device Issue (2379)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/16/2017
Event Type  malfunction  
Manufacturer Narrative
The reporter of the event was asked to return the product for analysis.To date, apollo has not received the device.Device labeling addresses the reported event as follows: balloon placement and inflation: note: during the filling process the fill tube must remain slack.If the fill tube is under tension during the intubation process, the fill tube may dislodge from the balloon, preventing further balloon deployment.Warning: rapid fill rates will generate high pressure which can damage the orbera system valve or cause premature detachment.A minimum fill volume of 400 ml is required for the balloon to deploy completely from the placement assembly.After filling the balloon, remove the fill kit from the fill tube.Connect a syringe directly to the fill tube luer-lock and produce a gentle suction on the placement catheter by withdrawing the plunger of the syringe.You will not withdraw fluid as the valve will seal with the vacuum created.
 
Event Description
Reported as: physician reported implanting a patient with the orbera intragastric balloon and noted "during implantation after injecting 360 ml of solution, the balloon disconnected." the physician chose to allow the balloon remain placed in the stomach.The device was implanted for little more than a month.At the time, patient then had an endoscopy and the physician noted "withered balloon.Fear of migrating and obstructing.Besides the insufficient weight, the balloon came with defect." the device was removed and replaced.
 
Manufacturer Narrative
Device evaluation summary: a visual examination was performed on the received balloon.The device was noted to be discolored, and the shell and center patch were blue in appearance.White particles were noted on the outer surface of the shell.An opening was noted on the posterior portion of the shell, approximately three inches from the center patch.The opening was circled in blue ink.As the device was not received with the fill tube, a sample fill tube was used for device testing.A valve test was performed, and the flow of di water was continuous and unobstructed.An air leak test was performed, and the balloon was leaking from three separate openings on the shell.Two openings on the anterior portion of the balloon were located approximately 1.5 inches from the center patch.Under microscopic analysis, the openings in the shell were noted to be sharp and striated, and consistent with damage from a removal tool.The third opening, which was circled in blue ink, was located on the posterior portion of the balloon, opposite the center patch and valve.The opening in the shell was noted to be striated, consistent with damage from a removal tool.Brown particulate matter was observed inside the valve channel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORBERA INTRAGASTRIC BALLOON SYSTEM
Type of Device
INTRAGASTRIC BALLOON
Manufacturer (Section D)
APOLLO ENDOSURGERY, INC.
1120 s capitol of texas hwy
bldg 1, ste 300
austin TX 78746
Manufacturer (Section G)
ALLERGAN
global park free zone
900 global park
la aurora de heredia
Manufacturer Contact
laura leboeuf
1120 s capitol of texas hwy
bldg 1, ste 300
austin, TX 78746
5122795100
MDR Report Key6555428
MDR Text Key74773967
Report Number3006722112-2017-00167
Device Sequence Number1
Product Code LTI
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
P140008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/18/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Physician
Device Expiration Date05/10/2018
Device Model NumberB-50000
Device Catalogue NumberB-50000
Device Lot Number2908358
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/05/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/29/2017
Initial Date FDA Received05/09/2017
Supplement Dates Manufacturer Received08/18/2017
Supplement Dates FDA Received08/23/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/10/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age23 YR
Patient Weight81
-
-